GNRSQ.US The Greenrose Holding Company Inc.

Healthcare Drug Manufacturers - Specialty & Generic USA Stocks
0.0001 USD
Close of Nov 14, 2026
0.0001 0.0001
Market cap
USD 1.77K
P/E
-
P/B
0.00x
ROE
-
Dividend yield
-
Fundamental score
-

Is GNRSQ.US undervalued?

Graham number

The Graham number of The Greenrose Holding Company Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

The Greenrose Holding Company Inc. fundamental analysis

No fundamental analysis for The Greenrose Holding Company Inc. yet.

The Greenrose Holding Company Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About The Greenrose Holding Company Inc.

On June 18, 2024, The Greenrose Holding Company Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of New York. The company, through its subsidiaries, previously engaged in the production and sale of cannabis products. It engaged in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.

Full company profile